Calidi Biotherapeutics, Inc. (CLDI) Operating cash flow 2022–2025
Calidi Biotherapeutics, Inc. (CLDI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$21.3MFY2025 · since FY2022: -$13.2M → -$21.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.3M | -8.1% |
| FY2024 | -$19.7M | +27.0% |
| FY2023 | -$27.0M | -104.2% |
| FY2022 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice